| abstract |
The present invention relates to new compounds of general formula (I), wherein the groups R 1 to R 3 , X 1 , X 2 , X 3 and L 1 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof in such a treatment. |